Skip to main content

Malik Fady Ibraham's Form 4 filing

Cytokinetics Inc (CYTK) · filed Dec 9, 2021

Accession no.
0001061983-21-000263
Filed
Dec 9, 2021
Trade date
Dec 9, 2021
Filing delay
Same day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.06M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Malik Fady IbrahamCIK 0001551778Officer (EVP Research & Development)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 9, 2021Common StockMOption exerciseAcquired+6,427$6.30+$40,490.1155,741Direct
Dec 9, 2021Common StockSSaleDisposed−6,427$36.49−$234,521.23149,314Direct
Dec 9, 2021Common StockMOption exerciseAcquired+22,739$6.30+$143,255.7172,053Direct
Dec 9, 2021Common StockSSaleDisposed−22,739$36.49−$829,746.11149,314Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 9, 2021Common StockMOption exerciseDisposed−22,739$0.00$00Direct
Dec 9, 2021Common StockMOption exerciseDisposed−6,427$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)